{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:12:45Z","timestamp":1793229165064,"version":"4.5.0"},"reference-count":187,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.meegid.2024.105703","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T12:26:56Z","timestamp":1733833616000},"page":"105703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["BCG's role in strengthening immune responses: Implications for tuberculosis and comorbid diseases"],"prefix":"10.1016","volume":"127","author":[{"given":"Nilofer","family":"Naqvi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashika","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheeba","family":"Zarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waseem","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Shariq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed E.","family":"Hasnain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasreen Z.","family":"Ehtesham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.meegid.2024.105703_bb0005","first-page":"2021","author":"(WHO), W.H.O","year":"2021","journal-title":"Global TB Rep."},{"key":"10.1016\/j.meegid.2024.105703_bb0010","first-page":"2022","author":"(WHO), W.H.O","year":"2022","journal-title":"Global TB Rep."},{"key":"10.1016\/j.meegid.2024.105703_bb0015","first-page":"2023","author":"(WHO), W.H.O","year":"2023","journal-title":"Global TB Rep."},{"key":"10.1016\/j.meegid.2024.105703_bb0020","doi-asserted-by":"crossref","first-page":"17317","DOI":"10.1073\/pnas.1215761109","article-title":"Saving lives by training innate immunity with bacille Calmette-Guerin vaccine","volume":"109","author":"Aaby","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.meegid.2024.105703_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.696734","article-title":"Mycobacterium-induced Th1, helminths-induced Th2 cells and the potential vaccine candidates for allergic asthma: imitation of natural infection","volume":"12","author":"Abdelaziz","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2024.105703_bb0030","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00291-19","article-title":"Curcumin nanoparticles enhance Mycobacterium bovis BCG vaccine efficacy by modulating host immune responses","volume":"87","author":"Ahmad","year":"2019","journal-title":"Infect. Immun."},{"key":"10.1016\/j.meegid.2024.105703_bb0035","article-title":"Mycobacterium tuberculosis specific protein Rv1509 evokes efficient innate and adaptive immune response indicative of protective Th1 immune signature","volume":"12","author":"Ahmad","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2024.105703_bb0040","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1016\/j.ymthe.2018.08.023","article-title":"Recombinant BCG overexpressing phoP-phoR confers enhanced protection against tuberculosis","volume":"26","author":"Ahn","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.meegid.2024.105703_bb0045","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.3389\/fimmu.2019.02247","article-title":"Immunosenescence and its hallmarks: how to oppose aging strategically? A review of potential options for therapeutic intervention","volume":"10","author":"Aiello","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2024.105703_bb0050","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1016\/j.vaccine.2007.03.039","article-title":"Oral administration of BCG encapsulated in alginate microspheres induces strong Th1 response in BALB\/c mice","volume":"25","author":"Ajdary","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2024.105703_bb0055","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.biochi.2011.09.026","article-title":"The PE\/PPE multigene family codes for virulence factors and is a possible source of mycobacterial antigenic variation: perhaps more?","volume":"94","author":"Akhter","year":"2012","journal-title":"Biochimie"},{"key":"10.1016\/j.meegid.2024.105703_bb0060","article-title":"Impact of the COVID-19 pandemic on tuberculosis control: an overview","volume":"5","author":"Alene","year":"2020","journal-title":"Trop. Med. Infect. Dis."},{"key":"10.1016\/j.meegid.2024.105703_bb0065","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3332\/ecancer.2019.905","article-title":"The use of intravesical BCG in urothelial carcinoma of the bladder","volume":"13","author":"Alhunaidi","year":"2019","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.meegid.2024.105703_bb0070","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1080\/21645515.2021.1956228","article-title":"Effectiveness of booster BCG vaccination in preventing Covid-19 infection","volume":"17","author":"Amirlak","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.meegid.2024.105703_bb0075","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrmicro1211","article-title":"The success and failure of BCG - implications for a novel tuberculosis vaccine","volume":"3","author":"Andersen","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.meegid.2024.105703_bb0080","doi-asserted-by":"crossref","first-page":"2300158","DOI":"10.1080\/21645515.2023.2300158","article-title":"Revamping the BCG revaccination strategy: records to recall, or just call it phoenix?","volume":"20","author":"Antas","year":"2024","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.meegid.2024.105703_bb0085","doi-asserted-by":"crossref","first-page":"18627","DOI":"10.1073\/pnas.2004421117","article-title":"Bacterial immunotherapy for cancer induces CD4-dependent tumor-specific immunity through tumor-intrinsic interferon-gamma signaling","volume":"117","author":"Antonelli","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.meegid.2024.105703_bb0090","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3389\/fimmu.2020.01199","article-title":"Immunodominant Mycobacterium tuberculosis protein Rv1507A elicits Th1 response and modulates host macrophage effector functions","volume":"11","author":"Arora","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2024.105703_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.564565","article-title":"Mycobacterium smegmatis Bacteria expressing Mycobacterium tuberculosis-specific Rv1954A induce macrophage activation and modulate the immune response","volume":"10","author":"Arora","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"89\u2013100","key":"10.1016\/j.meegid.2024.105703_bb0100","article-title":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.meegid.2024.105703_bb0105","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/08830185.2021.1922685","article-title":"Tuberculosis vaccine BCG: the magical effect of the old vaccine in the fight against the COVID-19 pandemic","volume":"41","author":"Aspatwar","year":"2022","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.meegid.2024.105703_bb0110","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.vaccine.2021.02.036","article-title":"Vaccines do not cause atopic dermatitis: a systematic review and meta-analysis","volume":"39","author":"Ayasse","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2024.105703_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11040853","article-title":"HIV\/Mtb co-infection: from the amplification of disease pathogenesis to an \u201cemerging Syndemic\u201d","volume":"11","author":"Azevedo-Pereira","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.meegid.2024.105703_bb0120","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/2251-6581-12-58","article-title":"Diabetes mellitus and tuberculosis facts and controversies","volume":"12","author":"Baghaei","year":"2013","journal-title":"J. Diabetes Metab. Disord."},{"key":"10.1016\/j.meegid.2024.105703_bb0125","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.2223\/JPED.1499","article-title":"BCG vaccine: efficacy and indications for vaccination and revaccination","volume":"82","author":"Barreto","year":"2006","journal-title":"J. Pediatr."},{"key":"10.1016\/j.meegid.2024.105703_bb0130","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4103\/0970-1591.166475","article-title":"Treatment options in non-muscle-invasive bladder cancer after BCG failure","volume":"31","author":"Brooks","year":"2015","journal-title":"Indian J Urol"},{"key":"10.1016\/j.meegid.2024.105703_bb0135","article-title":"Bacillus Calmette-Guerin immunotherapy for Cancer","volume":"9","author":"Cardillo","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.meegid.2024.105703_bb0140","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1080\/21645515.2019.1669414","article-title":"Recombinant BCG expressing the LTAK63 adjuvant induces increased early and long-term immune responses against mycobacteria","volume":"16","author":"Carvalho Dos Santos","year":"2020","journal-title":"Hum. Vaccin. Immunother."},{"issue":"Suppl. 1","key":"10.1016\/j.meegid.2024.105703_bb0145","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ijid.2021.02.107","article-title":"Global tuberculosis report 2020 - reflections on the global TB burden, treatment and prevention efforts","volume":"113","author":"Chakaya","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.meegid.2024.105703_bb0150","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s41579-022-00763-4","article-title":"Immune evasion and provocation by Mycobacterium tuberculosis","volume":"20","author":"Chandra","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.meegid.2024.105703_bb0155","doi-asserted-by":"crossref","first-page":"8954125","DOI":"10.1155\/2020\/8954125","article-title":"Therapeutic effects of BCG vaccination on type 1 diabetes mellitus: a systematic review and Meta-analysis of randomized controlled trials","volume":"2020","author":"Chang","year":"2020","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.meegid.2024.105703_bb0160","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jaci.2009.12.980","article-title":"Overview of the immune response","volume":"125","author":"Chaplin","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.meegid.2024.105703_bb0165","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12967-023-03944-8","article-title":"BCG-induced trained immunity: history, mechanisms and potential applications","volume":"21","author":"Chen","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.meegid.2024.105703_bb0170","doi-asserted-by":"crossref","first-page":"1250684","DOI":"10.1126\/science.1250684","article-title":"mTOR- and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity","volume":"345","author":"Cheng","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.meegid.2024.105703_bb0175","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41541-024-00834-y","article-title":"Antigen identification strategies and preclinical evaluation models for advancing tuberculosis vaccine development","volume":"9","author":"Chugh","year":"2024","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.meegid.2024.105703_bb0180","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pharmthera.2016.07.013","article-title":"The therapeutic potential of epigenetic manipulation during infectious diseases","volume":"167","author":"Cole","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.meegid.2024.105703_bb0185","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/S1473-3099(22)00222-5","article-title":"Safety and immunogenicity of VPM1002 versus BCG in south African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial","volume":"22","author":"Cotton","year":"2022","journal-title":"Lancet Infect. Dis."},{"issue":"10","key":"10.1016\/j.meegid.2024.105703_bb0190","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/S1473-3099(22)00222-5","article-title":"Safety and immunogenicity of VPM1002 versus BCG in south African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial","volume":"22","author":"Cotton","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.meegid.2024.105703_bb0195","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.3389\/fimmu.2019.02806","article-title":"BCG-induced cross-protection and development of trained immunity: implication for vaccine design","volume":"10","author":"Covian","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2024.105703_bb0200","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3389\/fimmu.2020.00970","article-title":"Could BCG vaccination induce protective trained immunity for SARS-CoV-2?","volume":"11","author":"Covian","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2024.105703_bb0205","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00262-019-02443-4","article-title":"Mechanisms of immune evasion in bladder cancer","volume":"69","author":"Crispen","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.meegid.2024.105703_bb0210","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.39169","article-title":"Mycobacterium tuberculosis induces decelerated bioenergetic metabolism in human macrophages","volume":"7","author":"Cumming","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.meegid.2024.105703_bb0215","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41586-019-1817-8","article-title":"Prevention of tuberculosis in macaques after intravenous BCG immunization","volume":"577","author":"Darrah","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.meegid.2024.105703_bb0220","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/cid\/civ144","article-title":"Nonspecific (heterologous) protection of neonatal BCG vaccination against hospitalization due to respiratory infection and Sepsis","volume":"60","author":"de Castro","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.meegid.2024.105703_bb0225","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fped.2019.00350","article-title":"Immune response to Mycobacterium tuberculosis: a narrative review","volume":"7","author":"de Martino","year":"2019","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.meegid.2024.105703_bb0230","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S2213-2600(22)00092-3","article-title":"The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions","volume":"10","author":"Dheda","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.meegid.2024.105703_bb0235","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41591-018-0319-9","article-title":"Prevention of tuberculosis infection and disease by local BCG in repeatedly exposed rhesus macaques","volume":"25","author":"Dijkman","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.meegid.2024.105703_bb0240","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3389\/fimmu.2017.01134","article-title":"What have we learnt about BCG vaccination in the last 20 years?","volume":"8","author":"Dockrell","year":"2017","journal-title":"Front. Immunol."},{"issue":"2659\u20132672","key":"10.1016\/j.meegid.2024.105703_bb0245","article-title":"beta-glucan-induced trained immunity protects against Leishmania braziliensis infection: a crucial role for IL-32","volume":"28","author":"Dos Santos","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.meegid.2024.105703_bb0250","article-title":"Recombinant BCG-LTAK63 vaccine candidate for tuberculosis induces an inflammatory profile in human macrophages","volume":"10","author":"Dos Santos","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.meegid.2024.105703_bb0255","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S1473-3099(23)00818-6","article-title":"Effect of BCG vaccination against Mycobacterium tuberculosis infection in adult Brazilian health-care workers: a nested clinical trial","volume":"24","author":"Dos Santos","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.meegid.2024.105703_bb0260","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1186\/s12879-019-4361-0","article-title":"Incidence of tuberculosis among HIV infected individuals on long term antiretroviral therapy in private healthcare sector in Pune, Western India","volume":"19","author":"Dravid","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.meegid.2024.105703_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.812774","article-title":"Toll-like receptor signaling and its role in cell-mediated immunity","volume":"13","author":"Duan","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2024.105703_bb0270","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/ijmr.IJMR_1563_20","article-title":"Will bacille Calmette-Guerin immunization arrest the COVID-19 pandemic?","volume":"152","author":"Ehtesham","year":"2020","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.meegid.2024.105703_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmm.2021.151495","article-title":"Teleological cooption of Mycobacterium tuberculosis PE\/PPE proteins as porins: role in molecular immigration and emigration","volume":"311","author":"Ehtram","year":"2021","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.meegid.2024.105703_bb0280","doi-asserted-by":"crossref","first-page":"17720","DOI":"10.1073\/pnas.2008410117","article-title":"BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)","volume":"117","author":"Escobar","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"13","key":"10.1016\/j.meegid.2024.105703_bb0285","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1245\/s10434-017-6072-3","article-title":"Long-term survival after complete surgical resection and adjuvant immunotherapy for distant melanoma metastases","volume":"24","author":"Faries","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.meegid.2024.105703_bb0290","article-title":"Multiple BCG vaccinations for the prevention of COVID-19 and other infectious diseases in type 1 diabetes","volume":"3","author":"Faustman","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.meegid.2024.105703_bb0295","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1016\/j.vaccine.2019.05.022","article-title":"SapM mutation to improve the BCG vaccine: genomic, transcriptomic and preclinical safety characterization","volume":"37","author":"Festjens","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2024.105703_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261246","article-title":"Diabetes mellitus and tuberculosis, a systematic review and meta-analysis with sensitivity analysis for studies comparable for confounders","volume":"16","author":"Foe-Essomba","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2024.105703_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/jb.92.1.1-5.1966","article-title":"Stimulation of nonspecific resistance to infection by a crude cell wall preparation from Mycobacterium phlei","volume":"92","author":"Fox","year":"1966","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.meegid.2024.105703_bb0310","first-page":"57","article-title":"Bacille Calmette Guerin (BCG) and new TB vaccines: specific, cross-mycobacterial and off-target effects","volume":"36","author":"Fritschi","year":"2020","journal-title":"Paediatr. Respir. Rev."},{"key":"10.1016\/j.meegid.2024.105703_bb0315","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.3389\/fimmu.2017.01960","article-title":"Immunosenescence and Inflamm-aging as two sides of the same coin: friends or foes?","volume":"8","author":"Fulop","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2024.105703_bb0320","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000086461","article-title":"BCG immunization at birth and atopic diseases in a homogeneous population of Spanish schoolchildren","volume":"137","author":"Garcia-Marcos","year":"2005","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.meegid.2024.105703_bb0325","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1038\/s41598-021-81057-2","article-title":"Diabetes among tuberculosis patients and its impact on tuberculosis treatment in South Asia: a systematic review and meta-analysis","volume":"11","author":"Gautam","year":"2021","journal-title":"Sci. Rep."},{"issue":"992\u20131000","key":"10.1016\/j.meegid.2024.105703_bb0330","article-title":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure","volume":"27","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"315\u2013323","key":"10.1016\/j.meegid.2024.105703_bb0335","article-title":"Activate: randomized clinical trial of BCG vaccination against infection in the elderly","volume":"183","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.meegid.2024.105703_bb0340","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1128\/IAI.01499-13","article-title":"rBCG30-induced immunity and cross-protection against Mycobacterium leprae challenge are enhanced by boosting with the Mycobacterium tuberculosis 30-kilodalton antigen 85B","volume":"82","author":"Gillis","year":"2014","journal-title":"Infect. Immun."},{"key":"10.1016\/j.meegid.2024.105703_bb0345","doi-asserted-by":"crossref","first-page":"4263079","DOI":"10.1155\/2020\/4263079","article-title":"Animal models of tuberculosis vaccine research: an important component in the fight against tuberculosis","volume":"2020","author":"Gong","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.meegid.2024.105703_bb0350","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01017-18","article-title":"The PGRS Domain of Mycobacterium tuberculosis PE_PGRS Protein Rv0297 Is Involved in Endoplasmic Reticulum Stress-Mediated Apoptosis through Toll-like Receptor 4","volume":"9","author":"Grover","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.meegid.2024.105703_bb0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/ITT.S202006","article-title":"Bacillus Calmette-Guerin (BCG) therapy for bladder Cancer: an update","volume":"9","author":"Guallar-Garrido","year":"2020","journal-title":"Immunotargets Ther."},{"key":"10.1016\/j.meegid.2024.105703_bb0360","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.951900","article-title":"When helpers go above and beyond: development and characterization of cytotoxic CD4(+) T cells","volume":"13","author":"Hoeks","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2024.105703_bb0365","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1086\/592450","article-title":"A new recombinant bacille Calmette-Guerin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers","volume":"198","author":"Hoft","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.meegid.2024.105703_bb0370","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ebiom.2016.04.010","article-title":"Safety and immunogenicity of the recombinant BCG vaccine AERAS-422 in healthy BCG-naive adults: a randomized, active-controlled, first-in-human phase 1 trial","volume":"7","author":"Hoft","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.meegid.2024.105703_bb0375","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1038\/s41467-019-10486-5","article-title":"Induction of memory-like dendritic cell responses in vivo","volume":"10","author":"Hole","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.meegid.2024.105703_bb0380","article-title":"Infections, Vaccines and Autoimmunity: A Multiple Sclerosis Perspective","volume":"8","author":"Jakimovski","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.meegid.2024.105703_bb0385","article-title":"Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies","volume":"5","author":"Jeon","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.meegid.2024.105703_bb0390","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133073","article-title":"BCG in bladder Cancer immunotherapy","volume":"14","author":"Jiang","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.meegid.2024.105703_bb0395","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.copbio.2012.03.007","article-title":"Recombinant live vaccine candidates against tuberculosis","volume":"23","author":"Kaufmann","year":"2012","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.meegid.2024.105703_bb0400","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1586\/14760584.2014.905746","article-title":"The BCG replacement vaccine VPM1002: from drawing board to clinical trial","volume":"13","author":"Kaufmann","year":"2014","journal-title":"Expert Rev. Vaccines"},{"issue":"176\u2013190","key":"10.1016\/j.meegid.2024.105703_bb0405","article-title":"BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis","volume":"172","author":"Kaufmann","year":"2018","journal-title":"Cell"},{"issue":"1\u20132","key":"10.1016\/j.meegid.2024.105703_bb0410","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2017.12.031","article-title":"BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis","volume":"172","author":"Kaufmann","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.meegid.2024.105703_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110502","article-title":"BCG vaccination provides protection against IAV but not SARS-CoV-2","volume":"38","author":"Kaufmann","year":"2022","journal-title":"Cell Rep."},{"issue":"10","key":"10.1016\/j.meegid.2024.105703_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110502","article-title":"BCG vaccination provides protection against IAV but not SARS-CoV-2","volume":"38","author":"Kaufmann","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.meegid.2024.105703_bb0425","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.cell.2020.09.062","article-title":"M. Tuberculosis reprograms hematopoietic stem cells to limit Myelopoiesis and impair trained immunity","volume":"183","author":"Khan","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.meegid.2024.105703_bb0430","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4111\/icu.20210425","article-title":"Immunotherapeutic effects of recombinant Bacillus Calmette-Guerin containing sic gene in ex vivo and in vivo bladder cancer models","volume":"63","author":"Kim","year":"2022","journal-title":"Investig. Clin. Urol."},{"key":"10.1016\/j.meegid.2024.105703_bb0435","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.meegid.2024.105703_bb0440","first-page":"9","article-title":"Recombinant BCG-Prime and DNA-Boost Immunization Confers Mice with Enhanced Protection against Mycobacterium kansasii","author":"Komine-Aizawa","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"42","key":"10.1016\/j.meegid.2024.105703_bb0445","doi-asserted-by":"crossref","first-page":"5715","DOI":"10.1016\/j.vaccine.2015.07.010","article-title":"Rhesus immune responses to SIV gag expressed by recombinant BCG vectors are independent from pre-existing mycobacterial immunity","volume":"33","author":"Korioth-Schmitz","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2024.105703_bb0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14760584.2017.1333906","article-title":"BCG and protection against inflammatory and auto-immune diseases","volume":"16","author":"Kowalewicz-Kulbat","year":"2017","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.meegid.2024.105703_bb0455","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/joim.13037","article-title":"Clinical and molecular insights into BCG immunotherapy for melanoma","volume":"288","author":"Kremenovic","year":"2020","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.meegid.2024.105703_bb0460","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/joim.13191","article-title":"Is mapping the BCG vaccine-induced immune responses the key to improving the efficacy against tuberculosis?","volume":"288","author":"Kuan","year":"2020","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.meegid.2024.105703_bb0465","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.tem.2018.11.006","article-title":"BCG therapy for type 1 diabetes: restoration of balanced immunity and metabolism","volume":"30","author":"Kuhtreiber","year":"2019","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.meegid.2024.105703_bb0475","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41541-018-0062-8","article-title":"Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations","volume":"3","author":"Kuhtreiber","year":"2018","journal-title":"NPJ Vaccines."},{"key":"10.1016\/j.meegid.2024.105703_bb0480","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.micinf.2004.10.002","article-title":"Memory in the innate and adaptive immune systems","volume":"6","author":"Kurtz","year":"2004","journal-title":"Microbes Infect."},{"key":"10.1016\/j.meegid.2024.105703_bb0485","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41541-023-00750-7","article-title":"Key advances in vaccine development for tuberculosis-success and challenges","volume":"8","author":"Lai","year":"2023","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.meegid.2024.105703_bb0490","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1038\/s41564-023-01503-x","article-title":"Intravenous Bacille Calmette-Guerin vaccination protects simian immunodeficiency virus-infected macaques from tuberculosis","volume":"8","author":"Larson","year":"2023","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.meegid.2024.105703_bb0495","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s10096-020-03843-6","article-title":"Tuberculosis vaccine development: from classic to clinical candidates","volume":"39","author":"Li","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.meegid.2024.105703_bb0500","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.3390\/curroncol31020079","article-title":"BCG and alternative therapies to BCG therapy for non-muscle-invasive bladder Cancer","volume":"31","author":"Lidagoster","year":"2024","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.meegid.2024.105703_bb0505","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s13238-020-00707-9","article-title":"Memory T cells: strategies for optimizing tumor immunotherapy","volume":"11","author":"Liu","year":"2020","journal-title":"Protein Cell"},{"key":"10.1016\/j.meegid.2024.105703_bb0510","article-title":"The association between diabetes mellitus and the risk of latent tuberculosis infection: a systematic review and Meta-analysis","volume":"9","author":"Liu","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.meegid.2024.105703_bb0515","doi-asserted-by":"crossref","first-page":"1100741","DOI":"10.3389\/fimmu.2023.1100741","article-title":"Maintenance and recall of memory T cell populations against tuberculosis: implications for vaccine design","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2024.105703_bb0520","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41585-021-00481-1","article-title":"100 years of Bacillus Calmette-Guerin immunotherapy: from cattle to COVID-19","volume":"18","author":"Lobo","year":"2021","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.meegid.2024.105703_bb0525","first-page":"53","article-title":"History of BCG Vaccine","volume":"8","author":"Luca","year":"2013","journal-title":"Maedica (Bucur)"},{"key":"10.1016\/j.meegid.2024.105703_bb0530","doi-asserted-by":"crossref","first-page":"6","DOI":"10.31083\/j.fbs1401006","article-title":"TB and COVID-19: an exploration of the characteristics and resulting complications of co-infection","volume":"14","author":"Luke","year":"2022","journal-title":"Front. Biosci. (Schol. Ed.)"},{"key":"10.1016\/j.meegid.2024.105703_bb0540","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s10020-021-00317-z","article-title":"Heterologous vaccine interventions: boosting immunity against future pandemics","volume":"27","author":"Marin-Hernandez","year":"2021","journal-title":"Mol. Med."},{"key":"10.1016\/j.meegid.2024.105703_bb0545","doi-asserted-by":"crossref","first-page":"e1307","DOI":"10.1016\/S2214-109X(22)00283-2","article-title":"Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis","volume":"10","author":"Martinez","year":"2022","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.meegid.2024.105703_bb0550","first-page":"18","article-title":"Risk Factors for Unfavorable Treatment Outcomes among the Human Immunodeficiency Virus-Associated Tuberculosis Population in Tashkent City, Uzbekistan: 2013-2017","author":"Massavirov","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.meegid.2024.105703_bb0555","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1126\/science.abd3871","article-title":"Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans","volume":"370","author":"Mateus","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.meegid.2024.105703_bb0560","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/pmj.78.922.449","article-title":"Use of bacille Calmette-Guerin in superficial bladder cancer","volume":"78","author":"Meyer","year":"2002","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.meegid.2024.105703_bb0565","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3389\/fimmu.2017.00407","article-title":"Immune responses to Bacillus Calmette-Guerin vaccination: why do they fail to protect against Mycobacterium tuberculosis?","volume":"8","author":"Moliva","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2024.105703_bb0570","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/mi.2017.80","article-title":"Exposure to human alveolar lining fluid enhances Mycobacterium bovis BCG vaccine efficacy against Mycobacterium tuberculosis infection in a CD8(+) T-cell-dependent manner","volume":"11","author":"Moliva","year":"2018","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.meegid.2024.105703_bb0575","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41385-019-0148-2","article-title":"Selective delipidation of Mycobacterium bovis BCG enables direct pulmonary vaccination and enhances protection against Mycobacterium tuberculosis","volume":"12","author":"Moliva","year":"2019","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.meegid.2024.105703_bb0580","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.cmi.2019.04.020","article-title":"Non-specific effects of BCG vaccine on viral infections","volume":"25","author":"Moorlag","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.meegid.2024.105703_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108387","article-title":"BCG vaccination induces long-term functional reprogramming of human neutrophils","volume":"33","author":"Moorlag","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.meegid.2024.105703_bb0590","article-title":"IV BCG Vaccination and Aerosol BCG Revaccination Induce Mycobacteria-Responsive Gammadelta T Cells Associated with Protective Efficacy against M. tb Challenge","volume":"11","author":"Morrison","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"10","key":"10.1016\/j.meegid.2024.105703_bb0595","article-title":"IV BCG vaccination and aerosol BCG revaccination induce mycobacteria-responsive gammadelta T cells associated with protective efficacy against M. Tb challenge","volume":"11","author":"Morrison","year":"2023","journal-title":"Vaccines (Basel)."},{"key":"10.1016\/j.meegid.2024.105703_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2020.152052","article-title":"BCG immunomodulation: from the \u2018hygiene hypothesis\u2019 to COVID-19","volume":"226","author":"Moulson","year":"2021","journal-title":"Immunobiology"},{"key":"10.1016\/j.meegid.2024.105703_bb0605","doi-asserted-by":"crossref","first-page":"7332","DOI":"10.1016\/j.vaccine.2021.09.053","article-title":"Effects of Mycobacterium bovis Calmette et Guerin (BCG) in oncotherapy: bladder cancer and beyond","volume":"39","author":"Mukherjee","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2024.105703_bb0610","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1073\/pnas.93.2.934","article-title":"Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guerin strains that secrete cytokines","volume":"93","author":"Murray","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.meegid.2024.105703_bb0615","article-title":"Immunological characterization of proteins expressed by genes located in Mycobacterium tuberculosis-specific genomic regions encoding the ESAT6-like proteins","volume":"9","author":"Mustafa","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.meegid.2024.105703_bb0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2021.104380","article-title":"Mast cells modulate early responses to Mycobacterium bovis Bacillus Calmette-Guerin by phagocytosis and formation of extracellular traps","volume":"365","author":"Naqvi","year":"2021","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.meegid.2024.105703_bb0625","doi-asserted-by":"crossref","DOI":"10.3390\/v16030321","article-title":"HIV-TB coinfection: current therapeutic approaches and drug interactions","volume":"16","author":"Navasardyan","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.meegid.2024.105703_bb0630","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.meegid.2024.105703_bb0635","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fimmu.2018.00121","article-title":"Next-generation vaccines based on Bacille Calmette-Guerin","volume":"9","author":"Nieuwenhuizen","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2024.105703_bb0640","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3389\/fimmu.2017.01147","article-title":"The recombinant Bacille Calmette-Guerin vaccine VPM1002: ready for clinical efficacy testing","volume":"8","author":"Nieuwenhuizen","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2024.105703_bb0645","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41581-022-00633-5","article-title":"Trained immunity - basic concepts and contributions to immunopathology","volume":"19","author":"Ochando","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.meegid.2024.105703_bb0650","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3143\/geriatrics.42.34","article-title":"Prevention of elderly pneumonia by pneumococcal, influenza and BCG vaccinations","volume":"42","author":"Ohrui","year":"2005","journal-title":"Nihon Ronen Igakkai Zasshi"},{"key":"10.1016\/j.meegid.2024.105703_bb0655","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41577-020-0337-y","article-title":"BCG-induced trained immunity: can it offer protection against COVID-19?","volume":"20","author":"O\u2019Neill","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.meegid.2024.105703_bb0660","article-title":"Protective efficacy of BCG vaccine against Mycobacterium leprae and non-tuberculous mycobacterial infections","volume":"10","author":"Orujyan","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.meegid.2024.105703_bb0665","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.meegid.2024.105703_bb0670","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nm859","article-title":"Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis","volume":"9","author":"Pym","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.meegid.2024.105703_bb0675","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1080\/21645515.2021.2007711","article-title":"BCG vaccination strategies against tuberculosis: updates and perspectives","volume":"17","author":"Qu","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.meegid.2024.105703_bb0680","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133788","article-title":"BCG vaccination reduces the mortality of Mycobacterium tuberculosis-infected type 2 diabetes mellitus mice","volume":"5","author":"Radhakrishnan","year":"2020","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.meegid.2024.105703_bb0685","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133788","article-title":"BCG vaccination reduces the mortality of Mycobacterium tuberculosis-infected type 2 diabetes mellitus mice","volume":"5","author":"Radhakrishnan","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.meegid.2024.105703_bb0690","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02020-14","article-title":"Comparative analyses of nonpathogenic, opportunistic, and totally pathogenic mycobacteria reveal genomic and biochemical variabilities and highlight the survival attributes of Mycobacterium tuberculosis","volume":"5","author":"Rahman","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.meegid.2024.105703_bb0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2020.100049","article-title":"BCG vaccination strategy implemented to reduce the impact of COVID-19: hype or Hope?","volume":"7","author":"Rajarshi","year":"2020","journal-title":"Med. Drug Discov."},{"key":"10.1016\/j.meegid.2024.105703_bb0700","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.130540","article-title":"BCG revaccination boosts adaptive polyfunctional Th1\/Th17 and innate effectors in IGRA+ and IGRA- Indian adults","volume":"4","author":"Rakshit","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.meegid.2024.105703_bb0705","article-title":"Therapeutic Potentials of Immunometabolomic Modulations Induced by Tuberculosis Vaccination","volume":"10","author":"Rawat","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.meegid.2024.105703_bb0710","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.euo.2021.12.006","article-title":"A phase 1\/2 single-arm clinical trial of recombinant Bacillus Calmette-Guerin (BCG) VPM1002BC immunotherapy in non-muscle-invasive bladder Cancer recurrence after conventional BCG therapy: SAKK 06\/14","volume":"5","author":"Rentsch","year":"2022","journal-title":"Eur. Urol. Oncol."},{"issue":"1","key":"10.1016\/j.meegid.2024.105703_bb0715","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1212\/01.wnl.0000438216.93319.ab","article-title":"Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS","volume":"82","author":"Ristori","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.meegid.2024.105703_bb0720","doi-asserted-by":"crossref","DOI":"10.1172\/JCI145157","article-title":"BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of health care workers","volume":"131","author":"Rivas","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.meegid.2024.105703_bb0725","doi-asserted-by":"crossref","DOI":"10.1172\/JCI145157","article-title":"BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of health care workers","volume":"131","author":"Rivas","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.meegid.2024.105703_bb0730","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.3389\/fimmu.2019.01460","article-title":"In vitro evidence of human immune responsiveness shows the improved potential of a recombinant BCG strain for bladder Cancer treatment","volume":"10","author":"Rodriguez","year":"2019","journal-title":"Front. Immunol."},{"issue":"3564\u20133579","key":"10.1016\/j.meegid.2024.105703_bb0735","article-title":"Compromised metabolic reprogramming is an early Indicator of CD8(+) T cell dysfunction during chronic Mycobacterium tuberculosis infection","volume":"29","author":"Russell","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.meegid.2024.105703_bb0740","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.12688\/f1000research.16521.1","article-title":"Research and development of new tuberculosis vaccines: a review","volume":"7","author":"Schrager","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.meegid.2024.105703_bb0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2020.101431","article-title":"Key recent advances in TB vaccine development and understanding of protective immune responses against Mycobacterium tuberculosis","volume":"50","author":"Scriba","year":"2020","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.meegid.2024.105703_bb0750","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41541-020-0169-6","article-title":"BCG and BCGDeltaBCG1419c protect type 2 diabetic mice against tuberculosis via different participation of T and B lymphocytes, dendritic cells and pro-inflammatory cytokines","volume":"5","author":"Segura-Cerda","year":"2020","journal-title":"NPJ Vaccin."},{"issue":"1","key":"10.1016\/j.meegid.2024.105703_bb0755","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41541-020-0169-6","article-title":"BCG and BCGDeltaBCG1419c protect type 2 diabetic mice against tuberculosis via different participation of T and B lymphocytes, dendritic cells and pro-inflammatory cytokines","volume":"5","author":"Segura-Cerda","year":"2020","journal-title":"NPJ Vaccines."},{"key":"10.1016\/j.meegid.2024.105703_bb0760","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.medj.2021.11.006","article-title":"Protection against tuberculosis by Bacillus Calmette-Guerin (BCG) vaccination: a historical perspective","volume":"3","author":"Setiabudiawan","year":"2022","journal-title":"Med"},{"key":"10.1016\/j.meegid.2024.105703_bb0765","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.tim.2020.03.015","article-title":"Chronic immune activation in TB\/HIV co-infection","volume":"28","author":"Sharan","year":"2020","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.meegid.2024.105703_bb0770","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0264-2021","article-title":"COVID-19 and tuberculosis: the double whammy of respiratory pathogens","volume":"31","author":"Shariq","year":"2022","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.meegid.2024.105703_bb0775","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.696491","article-title":"Mycobacterium tuberculosis protein PE6 (Rv0335c), a novel TLR4 agonist, evokes an inflammatory response and modulates the cell death pathways in macrophages to enhance intracellular survival","volume":"12","author":"Sharma","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2024.105703_bb0780","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010525","article-title":"The Mycobacterium tuberculosis PE_PGRS protein family acts as an immunological decoy to subvert host immune response","volume":"23","author":"Sharma","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.meegid.2024.105703_bb0785","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S1473-3099(19)30702-9","article-title":"Revisiting BCG to control tuberculosis: mucosal delivery and delipidation?","volume":"20","author":"Sheikh","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.meegid.2024.105703_bb0790","article-title":"Learning from COVID-19 to tackle TB pandemic: from despair to hope","volume":"2","author":"Sheikh","year":"2022","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"10.1016\/j.meegid.2024.105703_bb0795","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.GPP3-0022-2018","article-title":"Immunology of Mycobacterium tuberculosis infections","volume":"7","author":"Sia","year":"2019","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.meegid.2024.105703_bb0800","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1590\/s1806-37562017000000443","article-title":"Risk factors for tuberculosis: diabetes, smoking, alcohol use, and the use of other drugs","volume":"44","author":"Silva","year":"2018","journal-title":"J. Bras. Pneumol."},{"key":"10.1016\/j.meegid.2024.105703_bb0805","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.4049\/jimmunol.177.5.3250","article-title":"Processing and presentation of a mycobacterial antigen 85B epitope by murine macrophages is dependent on the phagosomal acquisition of vacuolar proton ATPase and in situ activation of cathepsin D","volume":"177","author":"Singh","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.meegid.2024.105703_bb0810","doi-asserted-by":"crossref","DOI":"10.1172\/JCI148291","article-title":"BCG turns 100: its nontraditional uses against viruses, cancer, and immunologic diseases","volume":"131","author":"Singh","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.meegid.2024.105703_bb0815","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41467-022-28509-z","article-title":"Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer","volume":"13","author":"Singh","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.meegid.2024.105703_bb0820","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41467-022-28509-z","article-title":"Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer","volume":"13","author":"Singh","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.meegid.2024.105703_bb0825","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.959656","article-title":"A century of BCG vaccination: immune mechanisms, animal models, non-traditional routes and implications for COVID-19","volume":"13","author":"Singh","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2024.105703_bb0830","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/infdis\/136.2.171","article-title":"Nonspecific protection of mice against influenza virus infection by local or systemic immunization with Bacille Calmette-Guerin","volume":"136","author":"Spencer","year":"1977","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.meegid.2024.105703_bb0835","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3181\/00379727-152-39327","article-title":"Effects of immunostimulants on resistance of newborn mice to herpes simplex type 2 infection","volume":"152","author":"Starr","year":"1976","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.meegid.2024.105703_bb0840","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.vaccine.2004.09.006","article-title":"Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls community based case-control study","volume":"23","author":"Stensballe","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2024.105703_bb0845","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3389\/fimmu.2019.01317","article-title":"The humoral immune response to BCG vaccination","volume":"10","author":"Tanner","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2024.105703_bb0850","doi-asserted-by":"crossref","first-page":"651","DOI":"10.31128\/AJGP-06-20-5490","article-title":"BCG vaccination: an update on current Australian practices","volume":"49","author":"Taylor","year":"2020","journal-title":"Aust. J. Gen. Pract."},{"key":"10.1016\/j.meegid.2024.105703_bb0855","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/iid3.260","article-title":"Allergic sensitization among Danish infants at 13 months of age","volume":"7","author":"Thostesen","year":"2019","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.meegid.2024.105703_bb0860","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101672","article-title":"Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies","volume":"65","author":"Tiwari","year":"2023","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.meegid.2024.105703_bb0865","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.jaci.2009.07.016","article-title":"Innate immunity","volume":"125","author":"Turvey","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"issue":"9","key":"10.1016\/j.meegid.2024.105703_bb0870","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.12014","article-title":"Association of BCG vaccination in childhood with subsequent Cancer diagnoses: a 60-year follow-up of a clinical trial","volume":"2","author":"Usher","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.meegid.2024.105703_bb0875","article-title":"The interaction of diabetes and tuberculosis: translating research to policy and practice. Trop med","volume":"6","author":"van Crevel","year":"2021","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.meegid.2024.105703_bb0880","first-page":"11","article-title":"Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections","author":"van Puffelen","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.meegid.2024.105703_bb0885","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3390\/vaccines1020120","article-title":"Nonclinical development of BCG replacement vaccine candidates","volume":"1","author":"Velmurugan","year":"2013","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.meegid.2024.105703_bb0890","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3390\/vaccines1020120","article-title":"Nonclinical development of BCG replacement vaccine candidates","volume":"1","author":"Velmurugan","year":"2013","journal-title":"Vaccines (Basel)."},{"issue":"1","key":"10.1016\/j.meegid.2024.105703_bb0895","article-title":"Stronger induction of trained immunity by mucosal BCG or MTBVAC vaccination compared to standard intradermal vaccination","volume":"2","author":"Vierboom","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.meegid.2024.105703_bb0900","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/S0264-410X(02)00241-4","article-title":"Enhanced immunogenicity of BCG vaccine by using a viral-based GM-CSF transgene adjuvant formulation","volume":"20","author":"Wang","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2024.105703_bb0905","first-page":"185","article-title":"The efficacy of Bacillus Calmette-Guerin vaccinations for the prevention of acute upper respiratory tract infection in the elderly","volume":"43","author":"Wardhana","year":"2011","journal-title":"Acta Med. Indones."},{"key":"10.1016\/j.meegid.2024.105703_bb0910","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1084\/jem.119.1.53","article-title":"Studies on the heterologous immunogenicity of a Menthanol-insoluble fraction of attenuated tubercle Bacilli (Bcg). I. Antimicrobial Protection","volume":"119","author":"Weiss","year":"1964","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.meegid.2024.105703_bb0915","article-title":"Influence of aerosol delivered BCG vaccination on immunological and disease parameters following SARS-CoV-2 challenge in Rhesus macaques","volume":"12","author":"White","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2024.105703_bb0920","article-title":"Heterologous prime-boost BCG with DNA vaccine expressing fusion antigens Rv2299c and Ag85A improves protective efficacy against Mycobacterium tuberculosis in mice","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.meegid.2024.105703_bb0925","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1080\/21645515.2019.1706930","article-title":"BCG: a vaccine with multiple faces","volume":"16","author":"Yamazaki-Nakashimada","year":"2020","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.meegid.2024.105703_bb0930","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fonc.2017.00061","article-title":"Insights into local tumor microenvironment immune factors associated with regression of cutaneous melanoma metastases by Mycobacterium bovis Bacille Calmette-Guerin","volume":"7","author":"Yang","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.meegid.2024.105703_bb0935","first-page":"1702578","article-title":"The bidirectional relationship between tuberculosis and diabetes","volume":"2017","author":"Yorke","year":"2017","journal-title":"Tuberc. Res. Treat."},{"key":"10.1016\/j.meegid.2024.105703_bb0940","doi-asserted-by":"crossref","first-page":"10587","DOI":"10.1007\/s00253-015-6962-x","article-title":"A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection","volume":"99","author":"Yuan","year":"2015","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.meegid.2024.105703_bb0945","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.157393","article-title":"Bacillus Calmette-Guerin-induced trained immunity protects against SARS-CoV-2 challenge in K18-hACE2 mice","volume":"7","author":"Zhang","year":"2022","journal-title":"JCI Insight"}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134824001552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134824001552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T11:50:54Z","timestamp":1736509854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134824001552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":187,"alternative-id":["S1567134824001552"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2024.105703","relation":{},"ISSN":["1567-1348"],"issn-type":[{"value":"1567-1348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BCG's role in strengthening immune responses: Implications for tuberculosis and comorbid diseases","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2024.105703","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105703"}}